BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8306457)

  • 21. Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms.
    Gonzalez-Quintela A; Campos J; Loidi L; Quinteiro C; Perez LF; Gude F
    Alcohol; 2008 Sep; 42(6):513-8. PubMed ID: 18579335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
    Miyoshi E; Nakano M
    Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
    Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
    Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood thiamine and thiamine phosphate ester concentrations in alcoholic and non-alcoholic liver diseases.
    Dancy M; Evans G; Gaitonde MK; Maxwell JD
    Br Med J (Clin Res Ed); 1984 Jul; 289(6437):79-82. PubMed ID: 6428686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease.
    Thompson S; Kelly CA; Griffiths ID; Turner GA
    Clin Chim Acta; 1989 Oct; 184(3):251-8. PubMed ID: 2611998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease.
    Ma Y; Meregalli M; Hodges S; Davies N; Bogdanos DP; Fargion S; Fiorelli G; Vergani D
    Int J Immunopathol Pharmacol; 2005; 18(1):173-82. PubMed ID: 15698522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastrointestinal hormones in alcoholic patients with and without liver disease.
    Dinsmore WW; Callender ME; Love AH; Buchanan KD
    Ulster Med J; 1986 Oct; 55(2):140-6. PubMed ID: 3811012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HFE genotypes in decompensated alcoholic liver disease: phenotypic expression and comparison with heavy drinking and with normal controls.
    Gleeson D; Evans S; Bradley M; Jones J; Peck RJ; Dube A; Rigby E; Dalton A
    Am J Gastroenterol; 2006 Feb; 101(2):304-10. PubMed ID: 16454835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and urinary fucose concentrations in hepatitis B-related cirrhosis and acute liver diseases.
    Sathish Kumar N; Eapen CE; Jeyamani R; Balasubramanian KA
    Clin Chim Acta; 2004 Apr; 342(1-2):233-5. PubMed ID: 15026286
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relationship between mean corpuscular volume, alcohol consumption, smoking habits, and alcoholic liver disease in hospitalized patients (author's transl)].
    Chaput JC; Lecomte MV; Poynard T; Buffet C; Labayle D; Etienne JP
    Gastroenterol Clin Biol; 1979 Mar; 3(3):221-6. PubMed ID: 456817
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
    Khan KN; Yatsuhashi H
    Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum carbohydrate-deficient transferrin in patients with nonalcoholic liver disease and with hepatocellular carcinoma.
    Murawaki Y; Sugisaki H; Yuasa I; Kawasaki H
    Clin Chim Acta; 1997 Mar; 259(1-2):97-108. PubMed ID: 9086297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases].
    Szalay F; Lakatos P; Németh J; Abonyi M; Büki B; Tarján G; Holló I
    Orv Hetil; 1991 Jun; 132(24):1301-5. PubMed ID: 1857606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].
    Pagani A; Pranzo A; Sala N; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):425-8. PubMed ID: 7938873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking.
    Nyblom H; Berggren U; Balldin J; Olsson R
    Alcohol Alcohol; 2004; 39(4):336-9. PubMed ID: 15208167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma glycoprotein variations in alcoholic hepatopathies after an oral ethanol overload: preliminary study].
    Ibarra de la Rosa I; Blanco FJ; Caballero Plasencia AM; Mora Lara JR
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):309-15. PubMed ID: 4001525
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and hematologic correlates of alcoholism and liver disease.
    Ryback RS; Eckardt MJ; Felsher B; Rawlings RR
    JAMA; 1982 Nov; 248(18):2261-5. PubMed ID: 7131677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
    Zhang S; Jiang K; Sun C; Lu H; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.